GlassScriptPhysician profile
Catherine Booth
NPI 1992908495
$880.27
in general payments reported to CMS, 2019-2025
12 companies · $104 in 2025
The $104 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $109 · 2021: $26.79 · 2022: $97.45 · 2023: $197 · 2024: $167 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Purelife, LLC | $200.00 | 2019-2020 | |
| Straumann USA LLC | $198.14 | 2022-2023 | |
| Align Technology, INC. | $149.16 | 2023-2025 | Invisalign, Itero Element 5d Plus |
| Zimvie INC. | $118.96 | 2024 | |
| Dentsply Sirona INC | $79.06 | 2021-2024 | Suresmile |
| Gc America INC. | $31.47 | 2019 | |
| Kulzer, LLC | $26.77 | 2019-2020 | |
| Nobel Biocare USA | $18.51 | 2023 | Nobelactive |
| Kerr Corporation | $16.58 | 2020 | |
| Patterson Companies, INC. | $15.00 | 2022 | |
| Philips North America LLC | $13.81 | 2019 | |
| Voco America INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.